- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech High Growth Stocks
Hong Kong Pharmaceuticals & Biotech High Growth Stocks
Results
3
0 new
High Growth Stocks
3 companies
WuXi XDC Cayman
Market Cap: HK$71.1b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$59.05
7D
-5.7%
1Y
218.2%
JBM (Healthcare)
Market Cap: HK$2.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$3.08
7D
7.7%
1Y
234.8%
Essex Bio-Technology
Market Cap: HK$3.2b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.71
7D
-2.4%
1Y
137.9%